Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06881940 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Study acronym: CARPTOX-BC
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to evaluate the effectiveness of a cardiac rehabilitation protocol, incorporating aerobic and resistance exercise, in reducing the incidence of cardiotoxicity in breast cancer patients receiving treatment with anthracyclines and/or trastuzumab through a randomized, active control group, open-label clinical trial.
Trial Details
NCT Number NCT06881940
Lead Sponsor Instituto Nacional de Cardiologia Ignacio Chavez
Collaborators: Instituto Nacional de Cancerologia de Mexico
Conditions
(from sponsor)		 Cancer Therapy-Related Cardiac Dysfunction
Related terms Breast Neoplasms, Cardiotoxicity
Enrollment 284 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov